Specific Pathogen Free
Specific Pathogen Free - Related Videos
03:45
A Bead-Based Multiplex Immunoassay to Identify Pathogen-Specific Antibodies in Saliva
0 Views •
2025
This video demonstrates a bead-based multiplex immunoassay technique to simultaneously detect antibodies for multiple environmental pathogens in human saliva. Fluorescent beads were coupled to antigens from different pathogens, which were captured using antibodies in the human saliva sample. Upon labeling the antibodies using a fluorescent reporter, the beads were analyzed using flow cytometry to assess the presence of different pathogen-specific antibodies in the saliva.
10:39
Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens
0 Views •
Cited by 22 •
2013
We describe a method for tracking the endomembrane rupture elicited by the intracellular bacteria Shigella flexneri and Mycobacterium tuberculosis upon host cell invasion. Our assay makes use of CCF4, a host cytoplasmic FRET probe in live or fixed cells. This reporter is degraded by an enzyme activity present on the bacterial surface.
01:30
Immunohistological Detection of Pathogens in Brain Tissue
0 Views •
2025
Wash to remove the paraffin, then rehydrate the tissue using decreasing alcohol concentrations.
12:54
Detection of Foodborne Bacterial Pathogens from Individual Filth Flies
0 Views •
Cited by 20 •
2015
A PCR-based protocol was adapted to detect Cronobacter spp., Salmonella enterica, and Listeria monocytogenes from body surfaces and alimentary canals of individual wild-caught flies. The goal of this protocol is to detect and isolate bacterial pathogens from individual insects collected as part of an environmental sampling program during foodborne outbreak investigations.
02:25
PCR-Based Detection of Foodborne Pathogens from Enriched Fly Samples
0 Views •
2026
Source: Pava-Ripoll, et al. Detection of Foodborne Bacterial Pathogens from Individual Filth Flies. J. Vis. Exp. (2015)This video demonstrates a PCR-based method that amplifies target bacterial DNA from enriched fly samples using pathogen-specific tablets, enabling real-time fluorescence detection and melting curve analysis to confirm the presence of foodborne pathogens in individual insects.
FAQs
Infections can alter drug absorption, immune responses, toxicity, and efficacy, creating biological variation unrelated to the compound being tested. Maintaining animals under Specific Pathogen Free conditions helps reduce these confounding effects, so differences between treatment groups are more likely to reflect pharmacological activity rather than unrecognized infectious influences. This supports more reproducible preclinical comparisons.
Specific Pathogen Free status applies only to the infectious agents included in the monitoring program. It does not mean that animals carry no microorganisms, so researchers must interpret the designation in relation to the tested pathogen panel and husbandry conditions. This limitation is important when comparing colonies or judging whether their health status fits a particular pharmacology study.
SPF status can change if animals encounter infectious agents or if barrier and husbandry controls fail. Routine microbiological screening provides evidence that the colony remains free of the specified pathogens, while ongoing surveillance identifies changes that could affect experimental consistency. In drug studies, this monitoring helps preserve confidence that infection-related factors have not emerged during the research period.
Several controls work together: controlled breeding or rederivation establishes the colony, barrier housing limits exposure, sterilized supplies reduce introduction of infectious agents, and routine microbiological screening checks health status. No single measure is sufficient on its own. Their combined use supports stable research populations and reduces the risk that husbandry-related infection will influence pharmacological observations.
They are particularly valuable when investigators need to compare drug absorption, immune responses, toxicity, or efficacy with minimal infection-related variation. A controlled health status can make treatment effects easier to distinguish from changes caused by infectious exposure. This is relevant to preclinical studies where reproducibility and safer interpretation of findings influence decisions about compound performance.
Researchers should treat SPF status as a control for specified infectious agents, not as proof that every biological variable is standardized. They should consider the colony’s pathogen panel, barrier conditions, sterilized supplies, and surveillance history when evaluating results. This context helps determine how confidently findings can be compared across studies and how safely they support pharmacological conclusions.